Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,242,523
-
Share change
-
+195,605
-
Total reported value
-
$64,263,216
-
Price per share
-
$19.82
-
Number of holders
-
42
-
Value change
-
+$3,934,001
-
Number of buys
-
27
-
Number of sells
-
8
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q2 2016
As of 30 Jun 2016,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,242,523 shares.
The largest 10 holders included
Vivo Capital, LLC, RA CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, SPHERA FUNDS MANAGEMENT LTD., Lombard Odier Asset Management (USA) Corp, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, Boxer Capital, LLC, and BlackRock Fund Advisors.
This page lists
42
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.